SIGA Technologies, Inc. (SIGA)
USD 5.19
(-3.71%)
USD 5.19
(-3.71%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 254.83 Million USD | 30.66% |
| 2022 | 195.03 Million USD | -9.17% |
| 2021 | 214.72 Million USD | 43.31% |
| 2020 | 149.83 Million USD | -24.54% |
| 2019 | 198.56 Million USD | -2.4% |
| 2018 | 203.44 Million USD | 40.63% |
| 2017 | 144.67 Million USD | -10.13% |
| 2016 | 160.98 Million USD | -13.33% |
| 2015 | 185.73 Million USD | 11.63% |
| 2014 | 166.38 Million USD | -14.16% |
| 2013 | 193.82 Million USD | 83.14% |
| 2012 | 105.83 Million USD | 17.1% |
| 2011 | 90.38 Million USD | 234.35% |
| 2010 | 27.03 Million USD | 4.31% |
| 2009 | 25.91 Million USD | 194.58% |
| 2008 | 8.79 Million USD | -16.92% |
| 2007 | 10.58 Million USD | -24.52% |
| 2006 | 14.02 Million USD | 129.77% |
| 2005 | 6.1 Million USD | -0.09% |
| 2004 | 6.11 Million USD | 0.18% |
| 2003 | 6.09 Million USD | 115.53% |
| 2002 | 2.82 Million USD | -32.74% |
| 2001 | 4.2 Million USD | 31.07% |
| 2000 | 3.21 Million USD | -5.58% |
| 1999 | 3.4 Million USD | -52.11% |
| 1998 | 7.1 Million USD | -36.04% |
| 1997 | 11.1 Million USD | 1750.0% |
| 1996 | 600 Thousand USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 243.14 Million USD | -4.59% |
| 2024 Q2 | 192.65 Million USD | -20.76% |
| 2023 FY | 254.83 Million USD | 30.66% |
| 2023 Q1 | 183.92 Million USD | -5.7% |
| 2023 Q2 | 146.51 Million USD | -20.34% |
| 2023 Q3 | 158.38 Million USD | 8.1% |
| 2023 Q4 | 254.83 Million USD | 60.9% |
| 2022 Q1 | 184.54 Million USD | -14.06% |
| 2022 Q2 | 159.94 Million USD | -13.33% |
| 2022 Q3 | 204.22 Million USD | 27.69% |
| 2022 Q4 | 195.03 Million USD | -4.5% |
| 2022 FY | 195.03 Million USD | -9.17% |
| 2021 Q4 | 214.72 Million USD | 58.4% |
| 2021 FY | 214.72 Million USD | 43.31% |
| 2021 Q3 | 135.56 Million USD | 1.4% |
| 2021 Q1 | 138.76 Million USD | -7.38% |
| 2021 Q2 | 133.68 Million USD | -3.66% |
| 2020 Q2 | 120.41 Million USD | 1.55% |
| 2020 Q4 | 149.83 Million USD | 5.95% |
| 2020 Q3 | 141.42 Million USD | 17.44% |
| 2020 FY | 149.83 Million USD | -24.54% |
| 2020 Q1 | 118.57 Million USD | -40.28% |
| 2019 Q1 | 206.43 Million USD | 1.47% |
| 2019 Q3 | 203.01 Million USD | -0.04% |
| 2019 Q2 | 203.09 Million USD | -1.62% |
| 2019 FY | 198.56 Million USD | -2.4% |
| 2019 Q4 | 198.56 Million USD | -2.19% |
| 2018 Q2 | 128.34 Million USD | -3.6% |
| 2018 Q4 | 203.44 Million USD | 41.55% |
| 2018 Q1 | 133.13 Million USD | -7.97% |
| 2018 FY | 203.44 Million USD | 40.63% |
| 2018 Q3 | 143.72 Million USD | 11.99% |
| 2017 Q3 | 148.72 Million USD | -4.68% |
| 2017 FY | 144.67 Million USD | -10.13% |
| 2017 Q1 | 160.82 Million USD | -0.1% |
| 2017 Q2 | 156.03 Million USD | -2.98% |
| 2017 Q4 | 144.67 Million USD | -2.73% |
| 2016 Q1 | 184.79 Million USD | -0.5% |
| 2016 Q4 | 160.98 Million USD | -1.14% |
| 2016 Q3 | 162.83 Million USD | -19.25% |
| 2016 Q2 | 201.66 Million USD | 9.13% |
| 2016 FY | 160.98 Million USD | -13.33% |
| 2015 Q2 | 182.46 Million USD | 5.32% |
| 2015 Q4 | 185.73 Million USD | -5.8% |
| 2015 Q3 | 197.16 Million USD | 8.06% |
| 2015 FY | 185.73 Million USD | 11.63% |
| 2015 Q1 | 173.23 Million USD | 4.12% |
| 2014 FY | 166.38 Million USD | -14.16% |
| 2014 Q4 | 166.38 Million USD | 1.01% |
| 2014 Q3 | 164.71 Million USD | -21.37% |
| 2014 Q2 | 209.47 Million USD | -2.48% |
| 2014 Q1 | 214.78 Million USD | 10.82% |
| 2013 Q1 | 128.72 Million USD | 21.63% |
| 2013 FY | 193.82 Million USD | 83.14% |
| 2013 Q4 | 193.82 Million USD | -3.84% |
| 2013 Q3 | 201.56 Million USD | 13.87% |
| 2013 Q2 | 177.01 Million USD | 37.51% |
| 2012 Q1 | 89.02 Million USD | -1.5% |
| 2012 Q3 | 92.05 Million USD | -0.64% |
| 2012 Q4 | 105.83 Million USD | 14.97% |
| 2012 Q2 | 92.64 Million USD | 4.06% |
| 2012 FY | 105.83 Million USD | 17.1% |
| 2011 Q3 | 50.78 Million USD | -2.28% |
| 2011 Q1 | 22.62 Million USD | -16.29% |
| 2011 FY | 90.38 Million USD | 234.35% |
| 2011 Q4 | 90.38 Million USD | 77.97% |
| 2011 Q2 | 51.96 Million USD | 129.67% |
| 2010 Q1 | 23.71 Million USD | -8.49% |
| 2010 Q3 | 23.67 Million USD | 6.82% |
| 2010 Q4 | 27.03 Million USD | 14.19% |
| 2010 FY | 27.03 Million USD | 4.31% |
| 2010 Q2 | 22.15 Million USD | -6.56% |
| 2009 FY | 25.91 Million USD | 194.58% |
| 2009 Q4 | 25.91 Million USD | 217.38% |
| 2009 Q3 | 8.16 Million USD | -3.07% |
| 2009 Q2 | 8.42 Million USD | 13.74% |
| 2009 Q1 | 7.4 Million USD | -15.81% |
| 2008 Q4 | 8.79 Million USD | -10.21% |
| 2008 FY | 8.79 Million USD | -16.92% |
| 2008 Q1 | 8.24 Million USD | -22.11% |
| 2008 Q2 | 9.99 Million USD | 21.2% |
| 2008 Q3 | 9.79 Million USD | -1.98% |
| 2007 FY | 10.58 Million USD | -24.52% |
| 2007 Q4 | 10.58 Million USD | -9.26% |
| 2007 Q3 | 11.66 Million USD | -6.53% |
| 2007 Q2 | 12.48 Million USD | -7.96% |
| 2007 Q1 | 13.56 Million USD | -3.3% |
| 2006 Q2 | 6.56 Million USD | 7.1% |
| 2006 FY | 14.02 Million USD | 129.77% |
| 2006 Q4 | 14.02 Million USD | 144.86% |
| 2006 Q3 | 5.72 Million USD | -12.71% |
| 2006 Q1 | 6.12 Million USD | 0.37% |
| 2005 Q4 | 6.1 Million USD | 42.54% |
| 2005 FY | 6.1 Million USD | -0.09% |
| 2005 Q2 | 4.51 Million USD | -11.36% |
| 2005 Q3 | 4.28 Million USD | -5.09% |
| 2005 Q1 | 5.09 Million USD | -16.68% |
| 2004 Q2 | 8.78 Million USD | -21.93% |
| 2004 Q4 | 6.11 Million USD | -28.65% |
| 2004 Q3 | 8.56 Million USD | -2.53% |
| 2004 Q1 | 11.25 Million USD | 84.51% |
| 2004 FY | 6.11 Million USD | 0.18% |
| 2003 FY | 6.09 Million USD | 115.53% |
| 2003 Q2 | 6.8 Million USD | 160.26% |
| 2003 Q3 | 6.28 Million USD | -7.66% |
| 2003 Q4 | 6.09 Million USD | -2.94% |
| 2003 Q1 | 2.61 Million USD | -7.6% |
| 2002 Q1 | 3.46 Million USD | -17.54% |
| 2002 Q4 | 2.82 Million USD | 48.28% |
| 2002 Q3 | 1.9 Million USD | -31.97% |
| 2002 Q2 | 2.8 Million USD | -19.14% |
| 2002 FY | 2.82 Million USD | -32.74% |
| 2001 Q2 | 2.68 Million USD | 0.97% |
| 2001 Q3 | 3.25 Million USD | 21.2% |
| 2001 Q1 | 2.65 Million USD | -17.16% |
| 2001 FY | 4.2 Million USD | 31.07% |
| 2001 Q4 | 4.2 Million USD | 29.3% |
| 2000 FY | 3.21 Million USD | -5.58% |
| 2000 Q3 | 4.45 Million USD | -19.79% |
| 2000 Q4 | 3.21 Million USD | -27.86% |
| 2000 Q1 | 6.57 Million USD | 93.35% |
| 2000 Q2 | 5.54 Million USD | -15.6% |
| 1999 Q3 | 4.2 Million USD | -17.65% |
| 1999 Q2 | 5.1 Million USD | -15.0% |
| 1999 Q1 | 6 Million USD | -15.49% |
| 1999 FY | 3.4 Million USD | -52.11% |
| 1999 Q4 | 3.4 Million USD | -19.05% |
| 1998 FY | 7.1 Million USD | -36.04% |
| 1998 Q2 | 8.5 Million USD | -15.0% |
| 1998 Q3 | 8.3 Million USD | -2.35% |
| 1998 Q4 | 7.1 Million USD | -14.46% |
| 1998 Q1 | 10 Million USD | -9.91% |
| 1997 FY | 11.1 Million USD | 1750.0% |
| 1997 Q4 | 11.1 Million USD | 14.43% |
| 1997 Q3 | 9.7 Million USD | 0.0% |
| 1996 FY | 600 Thousand USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Cosmos Health Inc. | 66.29 Million USD | -284.394% |
| Safety Shot Inc | 12.7 Million USD | -1905.135% |
| Bright Green Corporation | 17.4 Million USD | -1364.319% |
| Embecta Corp. | 1.21 Billion USD | 79.015% |
| ANI Pharmaceuticals, Inc. | 904.42 Million USD | 71.823% |
| Aquestive Therapeutics, Inc. | 57.41 Million USD | -343.826% |
| Collegium Pharmaceutical, Inc. | 1.14 Billion USD | 77.711% |
| Dynavax Technologies Corporation | 997.09 Million USD | 74.442% |
| Esperion Therapeutics, Inc. | 205.79 Million USD | -23.83% |
| Intra-Cellular Therapies, Inc. | 728.29 Million USD | 65.009% |
| Pacira BioSciences, Inc. | 1.57 Billion USD | 83.814% |
| PainReform Ltd. | 9.93 Million USD | -2466.326% |
| Sunshine Biopharma, Inc. | 27.34 Million USD | -831.863% |
| Sunshine Biopharma, Inc. | 27.34 Million USD | -831.863% |
| SCYNEXIS, Inc. | 128.41 Million USD | -98.452% |
| China SXT Pharmaceuticals, Inc. | 23.12 Million USD | -1001.896% |
| Journey Medical Corporation | 76.84 Million USD | -231.606% |
| Alpha Teknova, Inc. | 128.58 Million USD | -98.182% |
| Procaps Group, S.A. | 460.18 Million USD | 44.623% |
| Theratechnologies Inc. | 77.76 Million USD | -227.684% |
| Harrow Health, Inc. | 311.75 Million USD | 18.258% |
| Sonoma Pharmaceuticals, Inc. | 14.89 Million USD | -1611.114% |
| Biofrontera Inc. | 27.93 Million USD | -812.345% |
| DURECT Corporation | 45.18 Million USD | -463.934% |
| Supernus Pharmaceuticals, Inc. | 1.4 Billion USD | 81.913% |
| Cronos Group Inc. | 1.13 Billion USD | 77.533% |
| OptiNose, Inc. | 107.72 Million USD | -136.553% |
| Ironwood Pharmaceuticals, Inc. | 471.07 Million USD | 45.903% |
| Kala Pharmaceuticals, Inc. | 55.94 Million USD | -355.479% |
| RedHill Biopharma Ltd. | 23.04 Million USD | -1005.717% |
| Organogenesis Holdings Inc. | 460.02 Million USD | 44.604% |
| Guardion Health Sciences, Inc. | 11.91 Million USD | -2038.215% |
| Cumberland Pharmaceuticals Inc. | 81.77 Million USD | -211.627% |
| Radius Health, Inc. | 1.71 Billion USD | 85.149% |
| Universe Pharmaceuticals INC | 53.28 Million USD | -378.233% |
| ProPhase Labs, Inc. | 91.92 Million USD | -177.216% |
| Phibro Animal Health Corporation | 982.18 Million USD | 74.054% |
| Procaps Group S.A. | 460.18 Million USD | 44.623% |
| Alvotech | 950.09 Million USD | 73.178% |
| TherapeuticsMD, Inc. | 43.3 Million USD | -488.414% |
| Viatris Inc. | 47.68 Billion USD | 99.466% |
| Rockwell Medical, Inc. | 52.17 Million USD | -388.445% |
| Aytu BioPharma, Inc. | 118.09 Million USD | -115.789% |
| Tilray Brands, Inc. | 4.33 Billion USD | 94.122% |
| Lifecore Biomedical, Inc. | 273.7 Million USD | 6.893% |
| Shineco, Inc. | 84.17 Million USD | -202.73% |
| PetIQ, Inc. | 868.22 Million USD | 70.649% |
| Regencell Bioscience Holdings Limited | 8.43 Million USD | -2920.026% |
| Incannex Healthcare Limited | 17.04 Million USD | -1394.903% |
| Neurocrine Biosciences, Inc. | 3.25 Billion USD | 92.162% |
| Alimera Sciences, Inc. | 153.52 Million USD | -65.991% |
| Silver Spike Investment Corp. | 88.57 Million USD | -187.703% |
| Assertio Holdings, Inc. | 286.41 Million USD | 11.027% |
| Shuttle Pharmaceuticals Holdings, Inc. | 5.95 Million USD | -4181.712% |
| Petros Pharmaceuticals, Inc. | 33.79 Million USD | -654.047% |
| Clever Leaves Holdings Inc. | 31.24 Million USD | -715.659% |
| Cyclo Therapeutics, Inc. | 13.24 Million USD | -1823.649% |
| Avadel Pharmaceuticals plc | 261.12 Million USD | 2.409% |
| Hempacco Co., Inc. | 18.04 Million USD | -1312.376% |
| Talphera, Inc. | 20.39 Million USD | -1149.503% |
| Alvotech | 950.09 Million USD | 73.178% |
| Eagle Pharmaceuticals, Inc. | 406.16 Million USD | 37.257% |
| Lantheus Holdings, Inc. | 1.65 Billion USD | 84.566% |
| Currenc Group, Inc. | 141.49 Million USD | -80.108% |
| Kamada Ltd. | 351.96 Million USD | 27.597% |
| Indivior PLC | 1.95 Billion USD | 86.94% |
| Evoke Pharma, Inc. | 7.06 Million USD | -3505.214% |
| Flora Growth Corp. | 23.62 Million USD | -978.626% |
| Cyclo Therapeutics, Inc. | 13.24 Million USD | -1823.649% |
| Evolus, Inc. | 188.99 Million USD | -34.835% |
| HUTCHMED (China) Limited | 1.27 Billion USD | 80.087% |
| Amphastar Pharmaceuticals, Inc. | 1.51 Billion USD | 83.156% |
| Akanda Corp. | 8.83 Million USD | -2782.765% |